Divis Laboratories is currently trading at Rs 1292.00, up by 21.60 points or 1.70% from its previous closing of Rs 1270.40 on the BSE.
The scrip opened at Rs 1260.00 and has touched a high and low of Rs 1320.00 and Rs 1260.00 respectively. So far 12891 shares were traded on the counter.
The BSE group 'A' stock of face value Rs 2 has touched a 52 week high of Rs 1459.00 on 06-Mar-2014 and a 52 week low of Rs 905.00 on 05-Aug-2013.
Last one week high and low of the scrip stood at Rs 1286.20 and Rs 1227.40 respectively. The current market cap of the company is Rs 17221.61 crore.
The promoters holding in the company stood at 52.08% while Institutions and Non-Institutions held 30.28% and 17.63% respectively.
Divis Laboratories has undergone an inspection by the USFDA, with no major observations, for its Unit-II at Chippada village, Bheemunipatnam Mandal, near Visakhapatnam in state of Andhra Pradesh during June, 2014. The audit concluded with one observation primarily about further improvement of existing procedure. The purpose of this inspection was for Custom manufactured product.
Divis Laboratories, together with its subsidiaries, engaged in the manufacture and sale of active pharma ingredients (APIs) and intermediates for the pharmaceutical industry in India and worldwide.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1515.00 |
Dr. Reddys Lab | 6080.25 |
Cipla | 1565.50 |
Zydus Lifesciences | 1110.95 |
Lupin | 1601.00 |
View more.. |